GraftWorx (Alio) is honored to be nominated as a 1st Round Finalist, a Top 10 company, in the Best Cardiovascular Digital Diagnostic category for in the 2019 UCSF Health Awards! Read full article Related Articles June 23, 2022Alio Holds Inaugural Patient & Family Advisory Council MeetingBlog June 21, 2022Upcoming Webinar: Bending the Cost Curve in End-Stage Kidney DiseasePress Release May 17, 2022Alio Announces Patient and Family Advisory CouncilPress Release May 16, 2022Alio to Present in Upcoming ConferencesEvents May 3, 2022Alio Announces Terry Foust Litchfield Joining Board of DirectorsPress Release April 26, 2022Scott Davie Joins Alio as Chief Technology OfficerPress Release April 13, 2022Alio Receives First FDA 510(k) ClearancePress Release April 1, 2022Alio selected for NHS digital playbook for renal medicineMedia Coverage March 21, 2022Kidney Health: Help Address DisparitiesMedia Coverage March 3, 2022Alio to Participate in Upcoming ConferencesEvents
